Attached files
| file | filename |
|---|---|
| EX-10.2 - ELI LILLY AND COMPANY PERFORMANCE AWARD (FOR EXECUTIVE OFFICERS) - ELI LILLY & Co | lly-20161231x10kexhibit102.htm |
| EX-32 - SECTION 1350 CERTIFICATION - ELI LILLY & Co | lly-20161231x10kexhibit32.htm |
| EX-31.2 - RULE 13A-14(A) CERTIFICATION OF DERICA W. RICE, EXECUTIVE VICE PRESIDENT, GLOBAL - ELI LILLY & Co | lly-20161231x10kexhibit312.htm |
| EX-31 - RULE 13A-14(A) CERTIFICATION OF DAVID A. RICKS, PRESIDENT & CHIEF EXECUTIVE OFFI - ELI LILLY & Co | lly-20161231x10kexhibit311.htm |
| EX-21 - LIST OF SUBSIDIARIES AND AFFILIATES - ELI LILLY & Co | lly-20161231x10kexhibit21.htm |
| EX-12 - STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS (LOSS) TO FIXED CHARGES - ELI LILLY & Co | lly-20161231x10kexhibit12.htm |
| EX-10.3 - ELI LILLY AND COMPANY SHAREHOLDER VALUE AWARD (FOR EXECUTIVE OFFICERS) - ELI LILLY & Co | lly-20161231x10kexhibit103.htm |
| 10-K - 10-K - ELI LILLY & Co | lly-20161231x10xk.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3ASR Nos. 333-209627; and Form S-8 Nos. 333-104057 and 333-172422) of Eli Lilly and Company and subsidiaries and in the related Prospectus of our reports dated February 21, 2017, with respect to the consolidated financial statements of Eli Lilly and Company and subsidiaries, and the effectiveness of internal control over financial reporting of Eli Lilly and Company and subsidiaries, included in this Annual Report (10-K) for the year ended December 31, 2016.
/s/ Ernst and Young LLP
Indianapolis, Indiana
February 21, 2017